| Bjerkholt Eric |
CHIEF FINANCIAL OFFICER |
Mirum Pharmaceuticals, Inc. (MIRM)
|
2024-03-27 |
$24.80 |
67.9% |
2,000
|
$49,600 |
| Bjerkholt Eric |
CHIEF FINANCIAL OFFICER |
Mirum Pharmaceuticals, Inc. (MIRM)
|
2024-03-18 |
$25.80 |
61.4% |
2,000
|
$51,600 |
| Bjerkholt Eric |
Non-Executive Director |
CERUS CORP (CERS)
|
2023-12-13 |
$1.62 |
28.4% |
10,000
|
$16,200 |
| Bjerkholt Eric |
Chief Financial Officer |
Mirum Pharmaceuticals, Inc. (MIRM)
|
2023-09-11 |
$29.65 |
40.5% |
10,000
|
$296,492 |
| Bjerkholt Eric |
Non-Executive Director |
CERUS CORP (CERS)
|
2023-08-21 |
$1.72 |
21.3% |
10,000
|
$17,151 |
| Bjerkholt Eric |
Non-Executive Director |
CalciMedica, Inc. (CALC)
|
2023-05-31 |
$4.14 |
24.5% |
255
|
$1,055 |
| Bjerkholt Eric |
Non-Executive Director |
CERUS CORP (CERS)
|
2023-05-23 |
$2.00 |
4.0% |
5,000
|
$10,000 |
| Bjerkholt Eric |
Non-Executive Director |
CalciMedica, Inc. (CALC)
|
2023-05-23 |
$3.27 |
57.6% |
500
|
$1,634 |
| Bjerkholt Eric |
Non-Executive Director |
CalciMedica, Inc. (CALC)
|
2023-05-19 |
$2.65 |
94.3% |
200
|
$530 |
| Bjerkholt Eric |
Non-Executive Director |
CalciMedica, Inc. (CALC)
|
2023-05-18 |
$2.70 |
91.1% |
1,300
|
$3,504 |
| Bjerkholt Eric |
Non-Executive Director |
CERUS CORP (CERS)
|
2020-01-29 |
$4.15 |
-49.9% |
20,000
|
$83,000 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
29.7% |
$157,547 |
$530,766 |